$ZGNX Company News Zogenix to cut 37% of worke
Post# of 94266
Posted On: 01/04/2015 9:41:13 AM
$ZGNX Company News
Zogenix to cut 37% of workers to stretch its cash 8:38 a.m. June 5, 2013 - MarketWatch.com
Zogenix: FDA decision may be delayed past March 1 1:17 p.m. Feb. 27, 2013 - MarketWatch.com
Small is beautiful, tiny is even better 6:00 a.m. Jan. 2, 2013 - Mark Hulbert
Monday’s big movers: Mr. Dimon goes to Washington 5:16 p.m. Dec. 10, 2012 - Sue Chang
Zogenix offers 32.5M units of shares and warrants 9:40 a.m. July 24, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 2:35 p.m. July 16, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 4:36 p.m. March 9, 2012 - Kate Gibson
Updates, advisories and surprises 2:01 p.m. March 9, 2012 - MarketWatch
Zogenix tumbles on earnings report 1:04 p.m. March 9, 2012 - Val Brickates Kennedy
Zogenix climbs on earnings speculation 1:06 p.m. March 5, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:44 p.m. Jan. 6, 2012 - Kate Gibson
Zogenix puts 7.8% discount on 30 mln–share offer 12:44 p.m. Sept. 16, 2011 - MarketWatch.com
Zogenix to sell 12 mln shares to fund new drug 6:50 a.m. Aug. 24, 2011 - MarketWatch.com
Zogenix to seek FDA approval of chronic-pain drug 8:00 a.m. Aug. 17, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:41 p.m. Jan. 3, 2011 - MarketWatch
Anacor, Zogenix IPOs delayed 4:59 p.m. Nov. 19, 2010 - Val Brickates Kennedy
Zogenix (ZGNX) Looks Good: Stock Moves 8.9% Higher - Tale of the Tape 9:25 a.m. Dec. 31, 2014 - Zacks.com
Zogenix sets up expensive $24M credit facility 7:13 a.m. Dec. 31, 2014 - Seeking Alpha
Money flows into Zogenix today 3:49 p.m. Dec. 30, 2014 - Seeking Alpha
Zogenix (ZGNX) Stock Gets a Boost Today From This Coverage Initiation 1:36 p.m. Dec. 30, 2014 - TheStreet.com
Endo and BioDelivery Sciences submit NDA for transmucosal pain med 12:41 p.m. Dec. 25, 2014 - Seeking Alpha
FDA clears Purdue's abuse-deterrent opioid 1:36 p.m. Nov. 20, 2014 - Seeking Alpha
Zogenix's (ZGNX) CEO Roger Hawley on Q3 2014 Results - Earnings Call Transcript 9:01 p.m. Nov. 6, 2014 - Seeking Alpha
10-Q: ZOGENIX, INC. 5:09 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Zogenix (ZGNX) Q3 2014 Results - Earnings Call Webcast 4:25 p.m. Nov. 6, 2014 - Seeking Alpha
FDA clears Pfizer's abuse deterrent pain med 4:20 p.m. Oct. 17, 2014 - Seeking Alpha
Teva initiates rolling NDA for hydrocodone product 7:33 a.m. Oct. 8, 2014 - Seeking Alpha
Zogenix (ZGNX) Shows Strength: Stock Adds 11.2% in Session - Tale of the Tape 8:39 a.m. Oct. 6, 2014 - Zacks.com
8 Analyst Stocks Under $10 With Major Upside Calls 7:23 a.m. Oct. 4, 2014 - 247WallSt.com
Analyst Still Sees Zogenix Potentially Doubling 10:56 a.m. Oct. 2, 2014 - 247WallSt.com
Maker of Painkiller Tries to Curb Abuse 5:46 p.m. Oct. 1, 2014 - The Wall Street Journal Interactive Edition
Zogenix submits sNDA for abuse deterrent Zohydro 9:37 a.m. Oct. 1, 2014 - Seeking Alpha
10-Q: ZOGENIX, INC. 3:41 p.m. Aug. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Zogenix's (ZGNX) CEO Roger Hawley on Q2 2014 Results - Earnings Call Transcript 9:14 p.m. Aug. 5, 2014 - Seeking Alpha
Zogenix (ZGNX) Q2 2014 Results - Earnings Call Webcast 3:25 p.m. Aug. 5, 2014 - Seeking Alpha
FDA approves Purdue's oxycodone 4:33 p.m. July 23, 2014 - Seeking Alpha
Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 8:35 a.m. Dec. 15, 2014 - PR Newswire - PRF
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
Zogenix to Participate in Oppenheimer 25th Annual Healthcare Conference 4:32 p.m. Dec. 3, 2014 - GlobeNewswire
Results of Long-Term, Open-Label Study Published in the Journal of Pain Research Demonstrate the Safety, Tolerability and Effectiveness of Zohydro(R) ER 8:31 a.m. Dec. 1, 2014 - GlobeNewswire
Zogenix to Participate in Stifel 2014 Healthcare Conference 4:31 p.m. Nov. 12, 2014 - GlobeNewswire
Zogenix Reports Third Quarter 2014 Financial Results 4:07 p.m. Nov. 6, 2014 - GlobeNewswire
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix 8:55 a.m. Nov. 4, 2014 - PR Newswire - PRF
Zogenix and Purdue Pharma Exchange Waivers of Regulatory Exclusivity for Extended-Release Hydrocodone Products 7:31 a.m. Oct. 31, 2014 - GlobeNewswire
Zogenix Announces Conference Call and Webcast to Present Third Quarter 2014 Financial Results 3:15 p.m. Oct. 30, 2014 - GlobeNewswire
Zogenix Acquires U.K.-Based Brabant Pharma 6:32 a.m. Oct. 27, 2014 - GlobeNewswire
Zogenix Submits Modified Formulation of Zohydro(R) ER With Potential Abuse Deterrent Properties for FDA Review 7:31 a.m. Oct. 1, 2014 - GlobeNewswire
Pharma Equities Technical Momentum - Provectus Biopharma, Shire, Impax Labs, Zogenix, and TherapeuticsMD 7:30 a.m. Sept. 29, 2014 - PR Newswire - PRF
Education, Patient-Focused Approach to Treating Chronic Pain Are Keys to Preventing Opioid Abuse, Say Experts, Patients 6:31 a.m. Sept. 4, 2014 - GlobeNewswire
Zogenix to Participate in Morgan Stanley Global Healthcare Conference 2014 3:06 p.m. Sept. 2, 2014 - GlobeNewswire
Zohydro(R) ER Demonstrates Sustained 12-Hour Pain Relief 6:31 a.m. Sept. 2, 2014 - GlobeNewswire
Pharma Stocks Review -- Eli Lilly, Zogenix, GlaxoSmithKline, Novo Nordisk, and Valeant Pharma Intl. 8:20 a.m. Aug. 21, 2014 - PR Newswire - PRF
Zogenix Announces Departure of Chief Commercial Officer, Scott Shively 3:06 p.m. Aug. 1, 2014 - GlobeNewswire
Technical Coverage on Pharma Stocks -- GlaxoSmithKline, TherapeuticsMD, AstraZeneca, Zogenix, and Novartis 8:10 a.m. July 22, 2014 - PR Newswire - PRF
Zogenix Announces Conference Call and Webcast to Present Second Quarter 2014 Financial Results 8:00 a.m. July 22, 2014 - GlobeNewswire
Zogenix Announces Appointment of David Brushwood, J.D., R.Ph., to External Safe Use Board 7:31 a.m. July 17, 2014 - GlobeNewswire
Zogenix to cut 37% of workers to stretch its cash 8:38 a.m. June 5, 2013 - MarketWatch.com
Zogenix: FDA decision may be delayed past March 1 1:17 p.m. Feb. 27, 2013 - MarketWatch.com
Small is beautiful, tiny is even better 6:00 a.m. Jan. 2, 2013 - Mark Hulbert
Monday’s big movers: Mr. Dimon goes to Washington 5:16 p.m. Dec. 10, 2012 - Sue Chang
Zogenix offers 32.5M units of shares and warrants 9:40 a.m. July 24, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 2:35 p.m. July 16, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 4:36 p.m. March 9, 2012 - Kate Gibson
Updates, advisories and surprises 2:01 p.m. March 9, 2012 - MarketWatch
Zogenix tumbles on earnings report 1:04 p.m. March 9, 2012 - Val Brickates Kennedy
Zogenix climbs on earnings speculation 1:06 p.m. March 5, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:44 p.m. Jan. 6, 2012 - Kate Gibson
Zogenix puts 7.8% discount on 30 mln–share offer 12:44 p.m. Sept. 16, 2011 - MarketWatch.com
Zogenix to sell 12 mln shares to fund new drug 6:50 a.m. Aug. 24, 2011 - MarketWatch.com
Zogenix to seek FDA approval of chronic-pain drug 8:00 a.m. Aug. 17, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:41 p.m. Jan. 3, 2011 - MarketWatch
Anacor, Zogenix IPOs delayed 4:59 p.m. Nov. 19, 2010 - Val Brickates Kennedy
Zogenix (ZGNX) Looks Good: Stock Moves 8.9% Higher - Tale of the Tape 9:25 a.m. Dec. 31, 2014 - Zacks.com
Zogenix sets up expensive $24M credit facility 7:13 a.m. Dec. 31, 2014 - Seeking Alpha
Money flows into Zogenix today 3:49 p.m. Dec. 30, 2014 - Seeking Alpha
Zogenix (ZGNX) Stock Gets a Boost Today From This Coverage Initiation 1:36 p.m. Dec. 30, 2014 - TheStreet.com
Endo and BioDelivery Sciences submit NDA for transmucosal pain med 12:41 p.m. Dec. 25, 2014 - Seeking Alpha
FDA clears Purdue's abuse-deterrent opioid 1:36 p.m. Nov. 20, 2014 - Seeking Alpha
Zogenix's (ZGNX) CEO Roger Hawley on Q3 2014 Results - Earnings Call Transcript 9:01 p.m. Nov. 6, 2014 - Seeking Alpha
10-Q: ZOGENIX, INC. 5:09 p.m. Nov. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Zogenix (ZGNX) Q3 2014 Results - Earnings Call Webcast 4:25 p.m. Nov. 6, 2014 - Seeking Alpha
FDA clears Pfizer's abuse deterrent pain med 4:20 p.m. Oct. 17, 2014 - Seeking Alpha
Teva initiates rolling NDA for hydrocodone product 7:33 a.m. Oct. 8, 2014 - Seeking Alpha
Zogenix (ZGNX) Shows Strength: Stock Adds 11.2% in Session - Tale of the Tape 8:39 a.m. Oct. 6, 2014 - Zacks.com
8 Analyst Stocks Under $10 With Major Upside Calls 7:23 a.m. Oct. 4, 2014 - 247WallSt.com
Analyst Still Sees Zogenix Potentially Doubling 10:56 a.m. Oct. 2, 2014 - 247WallSt.com
Maker of Painkiller Tries to Curb Abuse 5:46 p.m. Oct. 1, 2014 - The Wall Street Journal Interactive Edition
Zogenix submits sNDA for abuse deterrent Zohydro 9:37 a.m. Oct. 1, 2014 - Seeking Alpha
10-Q: ZOGENIX, INC. 3:41 p.m. Aug. 6, 2014 - Edgar Online - (EDG = 10Q, 10K)
Zogenix's (ZGNX) CEO Roger Hawley on Q2 2014 Results - Earnings Call Transcript 9:14 p.m. Aug. 5, 2014 - Seeking Alpha
Zogenix (ZGNX) Q2 2014 Results - Earnings Call Webcast 3:25 p.m. Aug. 5, 2014 - Seeking Alpha
FDA approves Purdue's oxycodone 4:33 p.m. July 23, 2014 - Seeking Alpha
Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 8:35 a.m. Dec. 15, 2014 - PR Newswire - PRF
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
Zogenix to Participate in Oppenheimer 25th Annual Healthcare Conference 4:32 p.m. Dec. 3, 2014 - GlobeNewswire
Results of Long-Term, Open-Label Study Published in the Journal of Pain Research Demonstrate the Safety, Tolerability and Effectiveness of Zohydro(R) ER 8:31 a.m. Dec. 1, 2014 - GlobeNewswire
Zogenix to Participate in Stifel 2014 Healthcare Conference 4:31 p.m. Nov. 12, 2014 - GlobeNewswire
Zogenix Reports Third Quarter 2014 Financial Results 4:07 p.m. Nov. 6, 2014 - GlobeNewswire
Pharma Stocks on our Radar - Pfizer, Merck, Sanofi, Shire, and Zogenix 8:55 a.m. Nov. 4, 2014 - PR Newswire - PRF
Zogenix and Purdue Pharma Exchange Waivers of Regulatory Exclusivity for Extended-Release Hydrocodone Products 7:31 a.m. Oct. 31, 2014 - GlobeNewswire
Zogenix Announces Conference Call and Webcast to Present Third Quarter 2014 Financial Results 3:15 p.m. Oct. 30, 2014 - GlobeNewswire
Zogenix Acquires U.K.-Based Brabant Pharma 6:32 a.m. Oct. 27, 2014 - GlobeNewswire
Zogenix Submits Modified Formulation of Zohydro(R) ER With Potential Abuse Deterrent Properties for FDA Review 7:31 a.m. Oct. 1, 2014 - GlobeNewswire
Pharma Equities Technical Momentum - Provectus Biopharma, Shire, Impax Labs, Zogenix, and TherapeuticsMD 7:30 a.m. Sept. 29, 2014 - PR Newswire - PRF
Education, Patient-Focused Approach to Treating Chronic Pain Are Keys to Preventing Opioid Abuse, Say Experts, Patients 6:31 a.m. Sept. 4, 2014 - GlobeNewswire
Zogenix to Participate in Morgan Stanley Global Healthcare Conference 2014 3:06 p.m. Sept. 2, 2014 - GlobeNewswire
Zohydro(R) ER Demonstrates Sustained 12-Hour Pain Relief 6:31 a.m. Sept. 2, 2014 - GlobeNewswire
Pharma Stocks Review -- Eli Lilly, Zogenix, GlaxoSmithKline, Novo Nordisk, and Valeant Pharma Intl. 8:20 a.m. Aug. 21, 2014 - PR Newswire - PRF
Zogenix Announces Departure of Chief Commercial Officer, Scott Shively 3:06 p.m. Aug. 1, 2014 - GlobeNewswire
Technical Coverage on Pharma Stocks -- GlaxoSmithKline, TherapeuticsMD, AstraZeneca, Zogenix, and Novartis 8:10 a.m. July 22, 2014 - PR Newswire - PRF
Zogenix Announces Conference Call and Webcast to Present Second Quarter 2014 Financial Results 8:00 a.m. July 22, 2014 - GlobeNewswire
Zogenix Announces Appointment of David Brushwood, J.D., R.Ph., to External Safe Use Board 7:31 a.m. July 17, 2014 - GlobeNewswire
(0)
(0)